Adam D, Kasper S, Möller HJ, Singer EA (2005) Placebo-controlled trials in major depression are necessary and ethically justifiable: how to improve the communication between researchers and ethical committees. Eur Arch Psychiatry Clin Neurosci 255:258–260
CrossRefPubMedAmbuhl H, Grawe K (1988) The effects of psychotherapy as a result of the relation of therapeutic availability and acceptance by the client. Z Klin Psychol Psychopathol Psychother 36:308–327
PubMedAmbuhl H, Grawe K (1989) Psychotherapeutic activity as a realization of therapeutic heuristics. A process comparison of 3 therapy forms from a new perspective. Psychother Psychosom Med Psychol 39:1–10
PubMedArnold E, Grawe K (1989) Deskriptive Einzelfallanalysen – Eine Strategie zur Untersuchung von Wirkungszusammenhängen in der Psychotherapie. Z Klin Psychol Psychopathol Psychother 37:262–276
PubMedBaldwin D, Broich K, Fritze J et al (2003) Placebo-controlled studies in depression: necessary, ethical and feasible. Eur Arch Psychiatry Clin Neurosci 253:22–28
CrossRefPubMedBarth J, Munder T, Gerger H et al (2013) Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis. PLoS Med 10:e1001454
CrossRefPubMedPubMedCentralBateman A, Fonagy P (1999) Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry 156:1563–1569
CrossRefPubMedBaumann U, Stieglitz RD (1983) Test-Manual zum AMDP-System. Empirische Studien zur Psychopathologie. Springer, Berlin/Heidelberg/New York/Tokio
Beinlich P, Müller-Berghaus J, Sudhop T, Vieths S, Broich K (2015) Zusammenspiel zwischen Zulassung und Nutzenbewertung von Arzneimitteln. Bundesgesundheitsblatt 58:227–231
CrossRefBerger M, Klein HE (1984) Der Dexamethason-Suppressions-Test: Ein biologischer Marker der endogenen Depression? Eur Arch Psychiatry Neurol Sci 234:137–146
CrossRefPubMedBergin AE, Strupp HH (1972) Changing frontiers in the science of psychotherapy. Aldine, Chicago/New York
Brewin CR, Bradly C (1989) Patient preferences and randomised clinical trials. BMJ 299:313–315
Broich K (2005) Klinische Prüfungen mit Antidepressiva und Antipsychotika. Bundesgesundheitsblatt 48:541–547
CrossRefCampbell DT, Stanley JC (1963) Experimental and quasi-experimental designs for research on teaching. In: Gage NL (Hrsg) Handbook of research on teaching. Rand McNally, Chicago, S 117–246
Carnap R (1966) Philosphical foundations of physics. Nymphenburger Verlagsbuchhandlung. Dt. Übers. Hoering W, München/New York/London
Caspi A, Moffit TE (2006) Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 7:583–590
CrossRefPubMedCook TH, Campbell DT (1976) The design and conduct of quasi-experiments and true experiments in field settings. In: Dunnette MD (Hrsg) Handbook of industrial and organizational psychology. Rand McNally, Chicago, S 223–326
Cuijpers P, van Straten A, Warmerdam L et al (2009) Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Depress Anxiety 26:279–288
CrossRefPubMedCuijpers P, Berking M, Andersson G et al (2013) A metaanalysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry 58:376–385
PubMedFlint J, Cuijpers P, Horder J et al (2015) Is there an excess of significant findings in published studies of psychotherapy of depression. Psychol Med 45:439–446
CrossRefPubMedFountoulakis KN, Veroniki AA, Siamouli M et al (2013) No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis. Ann Gen Psychiatry 12:26
CrossRefPubMedPubMedCentralFrey S, von Zerssen D, Hansen W, Harders S (1979) Probleme der Verhaltensmessung in Einzelfalluntersuchungen. In: Petermann F, Hehl FJ (Hrsg) Einzelfall-Analyse. Urban & Schwarzenberg, München/Wien/Baltimore, S 159–182
Fritze J, Möller HJ (2001) Design of clinical trials of antidepressants. Should a placebo control arm be included? CNS Drugs 16:755–765
CrossRefGarfield SL (1973) Basic ingredients or common factors in psychotherapy. J Consult Clin Psychol 14:9–12
CrossRefGottman JM, Markman HJ (1978) Experimental designs in psychotherapy research. In: Garfield SL, Bergin AE (Hrsg) Handbook of psychotherapy and behavior change, 2. Aufl. Wiley, New York, S 23–63
Grawe K (1998) Psychologische Therapie. Hogrefe, Göttingen
Grawe K, Bernauer F, Donati R (1990) Psychotherapie im Vergleich: Haben wirklich alle einen Preis verdient? Psychother Psychosom Med Psychol 40:102–114
PubMedGrawe K, Donati R, Bernauer F (1994) Psychotherapie im Wandel. Von der Konfession zur Profession. Hogrefe, Göttingen
Greden JF, Gardner R, Kind D et al (1983) Dexamethasone suppression tests in antidepressant treatment of melancholia. Arch Gen Psychiatry 40:493–500
CrossRefPubMedGueorguieva R, Krystal JH (2004) MOVE over ANOVA: progress in analyzing repeated-measures data and its reflection in papers. Arch Gen Psychiatry 61:310–317
CrossRefPubMedHegerl U, Mergl R (2010) The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences. J Psychopharmacol 24:445–448
CrossRefPubMedHegerl U, Hautzinger M, Mergl R et al (2010) Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients’ choice arm. Int J Neuropsychopharmacol 13:31–44
CrossRefPubMedHelmchen H (2001) Therapeutische Wirksamkeit. Nervenarzt 72:56–60
CrossRefPubMedHoffmann SO, Gebhardt R (1973) Möglichkeiten der Kontrolle von psychotherapeutischen Ergebnissen. Prax Psychother 18:241–252
Huber G (1976) Zur Problematik quantitativer Verlaufsbeobachtungen bei Schizophrenen. Psychopathometrie 2:61–66
Janzarik W (1989) Menschenkundliche Anmerkungen zu Wissenschaft und Wissenschaftsbetrieb. Nervenarzt 60:612–618
PubMedJones PB, Barnes TR, Davies L et al (2006) Randomized controlled trial of the effect on quality of life of second- vs. first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 63:1079–1087
CrossRefPubMedKahn A, Leventhal RM, Khan SR, Brown WA (2002) Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database. J Clin Psychopharmacol 22:40–45
CrossRefKallert TW (2005) Braucht psychiatrische Versorgungsforschung randomisierte kontrollierte Studien? Psychiatr Prax 32:375–377
CrossRefPubMedKatschnig H, Simhandl C (1987) Neuere Ansätze in der Klassifikation und Diagnostik psychischer Krankheiten. In: Simhandl C, Berner P, Luccioni H, Alf C (Hrsg) Moderne Psychiatrie, Klassifikationsprobleme in der Psychiatrie. Medizinisch-Pharmazeutische Verlagsgesellschaft, Purkersdorf
Khan A, Faucett J, Lichtenberg P et al (2012) A systematic review of comparative efficacy of treatments and controls for depression. PLoS One 7:e41778
CrossRefPubMedPubMedCentralKiesler DJ (1977) Experimentelle Untersuchungspläne in der Psychotherapie-Forschung. In: Petermann F, Schmook C (Hrsg) Grundlagentexte der Klinischen Psychologie I. Huber, Bern/Stuttgart/Wien, S 106–148
Kirsch I (2002) The emperor’s new drug: an analysis of antidepressant medication data submitted to the U.S. food and drug administration. Prev Treat 5, No Pagination Specified, Article 23
Kuhn TS (1970) The structure of scientific revolutions. Enlarged. 2. Aufl. University of Chicago Press, Chicago
Leff JP, Vaughn CE (1980) The interaction of life events and relatives expressed emotion in schizophrenia and depressive neurosis. Br J Psychiatry 136:146–153
CrossRefPubMedLeichsenring F, Rabung S, Leibing E (2004) The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders. Arch Gen Psychiatry 61:1208–1216
CrossRefPubMedLeucht S, Corves C, Arbter D et al (2009a) Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373:31–41
CrossRefPubMedLeucht S, Komossa K, Rummel-Kluge C et al (2009b) A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am J Psychiatry 166:152–163
CrossRefPubMedLieberman JA, Stroup TS, McEvoy JP et al (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 352:1209–1223
CrossRefLinehan MM, Comtois KA, Murray AM et al (2006) Two-year randomized controlled trial and follow-up of dialectical behaviour therapy vs therapy by experts for suicidal behaviours and borderline personality disorder. Arch Gen Psychiatry 63:757–766
CrossRefPubMedLuborsky L, Chandler M, Auerbach A et al (1971) Factors influencing the outcome of psychotherapy: a review of quantitative research. Psychol Bull 75:145–185
CrossRefPubMedMaier W, Möller H-J (2010) Meta-analyses: a method to maximise the evidence from clinical studies? Eur Arch Psychiatry Clin Neurosci 260:17–23
CrossRefPubMedMallinckrodt CH, Raskin J, Wohlreich MM et al (2004) The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials. BMC Psychiatry 4:26
CrossRefPubMedPubMedCentralMeisenzahl EM, Scheuerecker J, Zipse M et al (2006) Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation. Eur Arch Psychiatry Clin Neurosci 256:522–531
CrossRefPubMedMeisenzahl EM, Schmitt G, Gründer G et al (2008) Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPECT study. Pharmacopsychiatry 41:169–175
CrossRefPubMedMöller HJ (1976) Methodische Grundprobleme der Psychiatrie. Kohlhammer, Stuttgart
Möller HJ (1978) Psychoanalyse – erklärende Wissenschaft oder Deutungskunst? Zur Grundlagendiskussion in der Psychowissenschaft. Fink, München
Möller HJ (1989) Standardisierte psychiatrische Befunderhebung. In: Kisker KP, Lauter H, Meyer JE et al (Hrsg) Psychiatrie der Gegenwart, Bd 9, 3. Aufl., Brennpunkte der Psychiatrie. Springer, Berlin/Heidelberg/New York/Tokio, S 13–45
CrossRefMöller HJ (1991) Outcome criteria in antidepressant drug trials: self-rating versus observer-rating scales. Pharmacopsychiatry 24:71–75
CrossRefPubMedMöller HJ (1998) Probleme der Klassifkation und Diagnostik. In: Reinecker H (Hrsg) Lehrbuch der Klinischen Psychologie, Modelle psychischer Störungen, 3. Aufl., Hogrefe, Göttingen/Toronto/Zürich, S 3–24
Möller HJ (2001) Methodological issues in psychiatry as an empirical science. World J Biol Psychiatry 2:38–47
CrossRefPubMedMöller HJ (2005) Problems associated with the classification and diagnosis of psychiatric disorders. World J Biol Psychiatry 6:45–56
CrossRefPubMedMöller HJ (2008a) Isn’t the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al 2008. Eur Arch Psychiatry Clin Neurosci 258:451–455
CrossRefPubMedMöller HJ (2008b) Do effectiveness („real world“) studies on antipsychotics tell us the real truth? Eur Arch Psychiatry Clin Neurosci 258:257–270
CrossRefPubMedMöller HJ (2009) Development of DSM-V and ICD-11: tendencies and potential of new classifications in psychiatry at the current state of knowledge. Psychiatry Clin Neurosci 63:595–612
CrossRefPubMedMöller HJ, Benkert O (1980) Methoden und Probleme der Beurteilung der Effektivität psychopharmakologischer und psychologischer Therapieverfahren. In: Biefang S (Hrsg) Evaluationsforschung in der Psychiatrie. Fragestellungen und Methoden. Enke, Stuttgart, S 54–128
Möller HJ, Broich K (2010) Principle standards and problems regarding proof of efficacy in clinical psychopharmacology. Eur Arch Psychiatry Clin Neurosci 260:3–16
CrossRefPubMedMöller H-J, Maier W (2010) Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations. Eur Arch Psychiatry Clin Neurosci 260:35–39
Möller HJ, Kissling W, Bottermann P (1986) The dexamethasone suppression test in depressive and schizophrenic patients under controlled treatment conditions. Eur Arch Psychiatry Neurol Sci 235:263–268
CrossRefPubMedMöller HJ, Blank R, Steinmeyer EM (1989) Single-case evaluation of sleep-deprivation effects by means of nonparametric time-series analysis (according to the HTAKA model). Eur Arch Psychiatry Neurol Sci 239:133–139
CrossRefPubMedMöller HJ, Langer S, Schmauss M (2007) Escitalopram in clinical practice: results of an open-label trial in outpatients with depression in a naturalistic setting in Germany. Pharmacopsychiatry 40:53–57
CrossRefPubMedMöller HJ, Bandelow B, Bauer M et al (2015a) DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences – part 1: general aspects and paradigmatic discussion of depressive disorders. Eur Arch Psychiatry Clin Neurosci 265:5–18
CrossRefPubMedMöller HJ, Bandelow B, Bauer M et al (2015b) DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences – part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders. Eur Arch Psychiatry Clin Neurosci 265:87–106
CrossRefPubMedMombour W (1972) Verfahren zur Standardisierung des psychopathologischen Befundes. Psychiatr Clin 5:73–120, /137–157
Muche R, Imhof A, SARAH-Studiengruppe (2003) Das Comprehensive Cohort Design als Alternative zur randomisierten kontrollierten Studie in der Rehabilitationsforschung: Vor- und Nachteile sowie Anwendungen in der SARAH-Studie. Rehabilitation 42:343–349
CrossRefPubMedMurphy GE, Carney RM, Kneserich MA et al (1995) Cognitive behavior therapy, relaxation training, and tricyclic antidepressant medication in the treatment of depression. Psychol Rep 77:403–420
CrossRefPubMedPalm U, Möller H-J (2011) Reception of Kraepelins idea’s 1900–1960. Psychiatry Clin Neurosci 65:301–325
CrossRefPaykel ES (2003) Life events and affective disorder. Acta Psychiatr Scand Suppl 418:61–66
CrossRefPubMedPetermann F (1977) Methodische Ansätze der Einzelfall-Analyse in der Psychotherapie-Forschung. In: Verhaltenstherapie. Kongreß-Bericht 1976. Herausgegeben von der Deutschen Gesellschaft für Verhaltenstherapie. Sonderheft I der „Mitteilungen der DGVT“
Petermann F, Hehl FJ, Schneider W (1977) Veränderungsmessungen im Rahmen der klassischen Test-Theorie. In: Petermann F (Hrsg) Methodische Grundlagen klinischer Psychologie. Beltz, Weinheim/Basel, S 129–154
Pogarell O, Juckel G, Norra C et al (2007) Prediction of clinical response to antidepressants in patients with depression: neurophysiology in clinical practice. Clin EEG Neurosci 38:74–77
CrossRefPubMedPopper KR (1969) Logik der Forschung, 3. Aufl. Mohr, Tübingen
Razin AM (1977) Effective psychotherapy. A handbook of research. Pergamon, Oxford
Rosenberg W, Donald A (1995) Evidence based medicine: an approach to clinical problem solving. BMJ 310:1122–1126
CrossRefPubMedPubMedCentralRush AJ, Trivedi MH, Wisniewski SR et al (2006) Acute and long-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163:1905–1917
CrossRefPubMedSackett DL, Rosenberg W, Gray JA et al (1996) Evidence-based medicine: what it is and what it isn’t. BMJ 312:71–72
CrossRefPubMedPubMedCentralSchmitt G-JE, Meisenzahl EM, Dresel S et al (2002) Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123-iodobenzamide SPECT: a comparative study with olanzapine. J Psychopharmacol 16:200–206
CrossRefPubMedSeemüller F, Riedel M, Obermeier M et al (2010) Outcomes of 1014 naturalistically treated inpatients with major depressive disorder. Eur Neuropsychopharmacol 20:346–355
CrossRefPubMedSeemüller F, Meier S, Obermeier M et al (2014) Three-year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors. Eur Arch Psychiatry Clin Neurosci 264:567–575
CrossRefPubMedSeidenstücker G, Baumann U (1978) Multimethodale Diagnostik. In: Baumann U, Berbalk H, Seidenstücker G (Hrsg) Klinische Psychologie. Trends in Forschung und Praxis I. Huber, Bern/Stuttgart/Wien, S 134–176
Stille G, Hippius H (1971) Kritische Stellungnahme zum Begriff der Neuroleptika (anhand von pharmakologischen und klinischen Befunden mit Clozapin). Pharmacopsychiatry 4:182–191
CrossRefTaves DR (1974) Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther 15:443–453
CrossRefPubMedTurner EH, Matthews AM, Linardatos E et al (2008) Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358:252–260
CrossRefPubMedÜberla K (1973) Versuchsplanung und Statistik in Phase II und III. Arzneimittelforschung (Drug Research) 23:1192–1196
von Zerssen D (1979) Klinisch-psychiatrische Selbstbeurteilungs-Fragebögen. In: Baumann U, Berbalk H, Seidenstücker G (Hrsg) Klinische Psychologie. Trends in Forschung und Praxis. Huber, Bern, S 130–159
von Zerssen D (1986) Clinical self-rating-scales (CSRF) of the Munich Psychiatric Information System (PSYHIS München). In: Sartorius N, Ban TA (Hrsg) Assessment of depression. Springer, Berlin/Heidelberg/New York/Tokio, S 270–303
CrossRefvon Zerssen D, Möller HJ (1980) Psychopathometrische Verfahren in der psychiatrischen Therapieforschung. In: Biefang S (Hrsg) Evaluationsforschung in der Psychiatrie: Fragestellungen und Methoden. Enke, Stuttgart, S 129–166
Woolf SH (1999) The need for perspective in evidence-based medicine. JAMA 282:2358–2365
CrossRefPubMedZimmermann M, Mattia JI, Posternak MA (2002) Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 2002(159):469–473
CrossRef